Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 15 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

7%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

5 recruiting

Enrollment Performance

Analytics

Phase 1
7(46.7%)
Phase 2
6(40.0%)
Phase 3
1(6.7%)
N/A
1(6.7%)
15Total
Phase 1(7)
Phase 2(6)
Phase 3(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (15)

Showing 15 of 15 trials
NCT07543796Phase 2Recruiting

Efficacy and Safety of TRD205 Tablets for Postoperative Analgesia in Unilateral Total Hip Arthroplasty (Phase IIb)

Role: lead

NCT07464912Phase 3Recruiting

A Adaptive Design Clinical Trial to Evaluate the Efficacy and Safety of TDI01 Suspension in the Treatment of Idiopathic Pulmonary Fibrosis (IPF)

Role: lead

NCT07371663Phase 1Recruiting

An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors

Role: lead

NCT07301203Phase 1Recruiting

Phase I Study of CPD704 Inhalation Suspension in Healthy Subjects

Role: lead

NCT06169722Phase 1Active Not Recruiting

TDI01 Suspension in the Treatment of Chronic Graft-versus-host Disease (cGVHD))

Role: lead

NCT07123402Phase 2Enrolling By Invitation

To Evaluate the Efficacy and Safety of TRD205 Tablets in the Treatment of Chronic Postoperative Neuralgia

Role: lead

NCT07123428Phase 1Completed

Single and Multiple Ascending Doses and Food Effect Study of TRD205 in Healthy Volunteers

Role: lead

NCT07121101Phase 2Not Yet Recruiting

To Evaluate the Safety, Efficacy and Kinetic Characteristics of TRD205 Tablets for Postoperative Analgesia After Unilateral Hip Arthroplasty

Role: lead

NCT07121023Phase 1Not Yet Recruiting

To Evaluate the Safety, Efficacy and Kinetic Characteristics of TRD205 Tablets for Postoperative Analgesia After Unilateral Hallux Valgus Orthopedic Surgery

Role: lead

NCT05970016Phase 1Recruiting

A Phase I/II Clinical Study in Patients with Advanced Solid Tumor.

Role: lead

NCT06213363Phase 1Unknown

A Phase Ib/II Clinical Study in Patients With Refractory Chronic Cough

Role: lead

NCT06102083Phase 2Not Yet Recruiting

A Clinical Trial on the Treatment of Idiopathic Pulmonary Fibrosis

Role: lead

NCT05950152Phase 2Unknown

Efficacy, Safety and Tolerability Study of Meloxicam Injection in Subjects After Abdominal Surgery

Role: lead

NCT03995732Phase 2Unknown

Efficacy and Safety Evaluation of PC-SOD for Injection in Reducing Myocardial Reperfusion Injury

Role: lead

NCT02030769Not ApplicableCompleted

Pronase Improves Efficacy of Chromoendoscopy Screening on Esophageal Cancer

Role: collaborator

All 15 trials loaded